DiaMedica Therapeutics Inc.
NASDAQDiaMedica Therapeutics heads into its May 7 results with options traders decidedly bullish and short sellers maintaining a meaningful — but softening — position in the lending market. The clearest bullish signal is in options. The put/call ratio has dropped to just 0.12, well below its 20-day average of 0.17, indicating that call demand is dominating and downside protection is…
Snapshot as of 22 Jun 2026
DiaMedica Therapeutics heads into its May 7 results with options traders decidedly bullish and short sellers maintaining a meaningful — but softening — position in the lending market. The clearest bullish signal is in…
DiaMedica Therapeutics just crossed two catalysts in 48 hours, and short sellers are watching carefully. Q1 2026 results, released after market close on May 6, came in at -$0.19 per share — inline with expectations.…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for DMAC — free to start on ORTEX.
Sign up for free →Open DMAC on ORTEX